Assignee
ROGCON INC
US·1 granted patent·1 pending application·0 citations·filing 2019–2024
Top patents by PatentIndex Score
2 records- 0167US2024294922A1Antisense oligonucleotides targeting scn2a for the treatment of scn1a encephalopathiesROGCON INC·Filed 2024·Application pending·0 cites
- 0257US11939582B2Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathiesROGCON INC·Filed 2019·Granted Mar 26, 2024·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when ROGCON INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →